Biotechnology
The Biotechnology industry has a total of 678 stocks, with a combined market cap of $1,462.7 billion and total revenue of $121.74 billion.
Market Cap
1,462.70B
Revenue
121.74B
Profits
-33.35B
PE Ratio
n/a
Profit Margin
-27.39%
Dividend Yield
0.09%
678 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 585.45B | -1.17% | 1,895,655 | 35.35B |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 114.72B | 0.90% | 554,241 | 10.19B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 106.02B | 1.08% | 219,834 | 13.10B |
| 4 | MRNA | Moderna, Inc. | 50.49B | -0.73% | 1,831,891 | 5.15B |
| 5 | ARGX | argenx SE | 21.67B | -3.21% | 72,881 | 39.48M |
| 6 | BNTX | BioNTech SE | 21.64B | -2.30% | 289,529 | 2.97B |
| 7 | GMAB | Genmab A/S | 19.44B | 0.64% | 136,705 | 2.57B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 18.83B | -1.63% | 194,700 | 2.00B |
| 9 | BGNE | BeiGene, Ltd. | 18.57B | 1.06% | 207,484 | 2.76B |
| 10 | BMRN | BioMarin Pharmaceutical Inc. | 14.74B | 0.92% | 2,297,337 | 2.47B |
| 11 | TECH | Bio-Techne Corporation | 13.21B | 1.00% | 793,563 | 1.15B |
| 12 | INCY | Incyte Corporation | 12.82B | 0.44% | 771,731 | 3.77B |
| 13 | RPRX | Royalty Pharma plc | 12.34B | -1.83% | 1,146,170 | 2.24B |
| 14 | SRPT | Sarepta Therapeutics, Inc. | 12.27B | -2.32% | 501,936 | 1.40B |
| 15 | UTHR | United Therapeutics Corporation | 12.13B | 0.47% | 136,741 | 2.50B |
| 16 | ROIV | Roivant Sciences Ltd. | 9.04B | -1.67% | 2,594,894 | 123.24M |
| 17 | LEGN | Legend Biotech Corporation | 8.19B | -3.13% | 327,567 | 342.80M |
| 18 | PCVX | Vaxcyte, Inc. | 8.13B | -1.25% | 331,413 | - |
| 19 | CERE | Cerevel Therapeutics Holdings, Inc. | 7.68B | -0.43% | 809,563 | - |
| 20 | VKTX | Viking Therapeutics, Inc. | 7.42B | -2.29% | 2,933,144 | - |
| 21 | JAZZ | Jazz Pharmaceuticals plc | 6.84B | -1.89% | 302,559 | 3.84B |
| 22 | ASND | Ascendis Pharma A/S | 6.82B | -1.95% | 368,854 | 357.63M |
| 23 | BPMC | Blueprint Medicines Corporation | 6.60B | -1.19% | 180,711 | 282.21M |
| 24 | RVMD | Revolution Medicines, Inc. | 6.46B | 0.42% | 489,330 | 4.57M |
| 25 | CYTK | Cytokinetics, Incorporated | 6.26B | -0.37% | 541,974 | 3.75M |
| 26 | EXEL | Exelixis, Inc. | 6.07B | -1.84% | 729,073 | 1.85B |
| 27 | HALO | Halozyme Therapeutics, Inc. | 5.65B | -2.20% | 510,819 | 862.99M |
| 28 | BBIO | BridgeBio Pharma, Inc. | 5.55B | -4.38% | 1,313,242 | 218.60M |
| 29 | IONS | Ionis Pharmaceuticals, Inc. | 5.35B | -2.53% | 767,779 | 776.62M |
| 30 | IBRX | ImmunityBio, Inc. | 5.34B | -0.71% | 2,894,340 | 302.00K |
| 31 | APLS | Apellis Pharmaceuticals, Inc. | 5.02B | -1.77% | 494,533 | 524.07M |
| 32 | CRSP | CRISPR Therapeutics AG | 4.71B | -0.52% | 684,984 | 271.71M |
| 33 | MDGL | Madrigal Pharmaceuticals, Inc. | 4.64B | 0.27% | 127,149 | - |
| 34 | KRYS | Krystal Biotech, Inc. | 4.62B | -0.41% | 77,874 | 95.95M |
| 35 | NUVL | Nuvalent, Inc. | 4.58B | -2.30% | 187,352 | - |
| 36 | ALPN | Alpine Immune Sciences, Inc. | 4.46B | 0.05% | 692,573 | 56.52M |
| 37 | IMVT | Immunovant, Inc. | 4.44B | -2.83% | 321,310 | - |
| 38 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.06B | -1.00% | 308,305 | 1.97M |
| 39 | INSM | Insmed Incorporated | 3.68B | -1.14% | 619,489 | 315.49M |
| 40 | AXSM | Axsome Therapeutics, Inc. | 3.68B | -0.36% | 295,889 | 251.02M |
| 41 | RARE | Ultragenyx Pharmaceutical Inc. | 3.48B | -1.37% | 448,306 | 442.59M |
| 42 | BHVN | Biohaven Pharmaceutical Holding Company Ltd. | 3.31B | -2.55% | 382,092 | - |
| 43 | SWTX | SpringWorks Therapeutics, Inc. | 3.28B | -1.23% | 358,861 | 26.45M |
| 44 | SMMT | Summit Therapeutics Inc. | 3.12B | -1.33% | 562,847 | - |
| 45 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.08B | -0.88% | 330,264 | 35.47M |
| 46 | IDYA | IDEAYA Biosciences, Inc. | 3.05B | -3.27% | 409,157 | 15.50M |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 3.00B | -1.61% | 86,173 | - |
| 48 | APGE | Apogee Therapeutics, Inc. | 2.99B | -5.08% | 208,740 | - |
| 49 | DNLI | Denali Therapeutics Inc. | 2.92B | 1.04% | 271,113 | 295.39M |
| 50 | CORT | Corcept Therapeutics Incorporated | 2.90B | 1.27% | 420,527 | 523.53M |
| 51 | IOVA | Iovance Biotherapeutics, Inc. | 2.87B | -1.92% | 2,831,141 | 1.90M |
| 52 | ACLX | Arcellx, Inc. | 2.84B | 0.57% | 241,412 | 131.66M |
| 53 | FOLD | Amicus Therapeutics, Inc. | 2.79B | -0.74% | 944,241 | 423.49M |
| 54 | RNA | Avidity Biosciences, Inc. | 2.77B | 1.06% | 480,474 | 10.87M |
| 55 | MOR | MorphoSys AG | 2.77B | -1.78% | 429,721 | 264.75M |
| 56 | IMCR | Immunocore Holdings plc | 2.67B | -1.38% | 632,170 | 264.25M |
| 57 | MRUS | Merus N.V. | 2.59B | -2.13% | 243,521 | 38.34M |
| 58 | TGTX | TG Therapeutics, Inc. | 2.54B | -6.08% | 1,932,036 | 289.33M |
| 59 | PTCT | PTC Therapeutics, Inc. | 2.54B | -2.53% | 281,929 | 927.56M |
| 60 | NTLA | Intellia Therapeutics, Inc. | 2.52B | -0.11% | 546,869 | 52.60M |
| 61 | CLDX | Celldex Therapeutics, Inc. | 2.52B | -4.21% | 224,835 | 6.07M |
| 62 | MLTX | MoonLake Immunotherapeutics | 2.50B | -2.84% | 131,071 | - |
| 63 | FTRE | Fortrea Holdings Inc. | 2.47B | -0.58% | 807,492 | 3.11B |
| 64 | JANX | Janux Therapeutics, Inc. | 2.44B | -0.93% | 258,584 | 7.29M |
| 65 | ACAD | ACADIA Pharmaceuticals Inc. | 2.44B | -0.44% | 732,858 | 813.81M |
| 66 | VCEL | Vericel Corporation | 2.34B | 1.20% | 133,373 | 207.78M |
| 67 | RYTM | Rhythm Pharmaceuticals, Inc. | 2.29B | -4.34% | 299,386 | 91.93M |
| 68 | GERN | Geron Corporation | 2.26B | -2.18% | 3,480,737 | 520.00K |
| 69 | VERA | Vera Therapeutics, Inc. | 2.26B | -2.03% | 160,202 | - |
| 70 | RXRX | Recursion Pharmaceuticals, Inc. | 2.24B | -1.00% | 3,182,984 | 46.24M |
| 71 | ARVN | Arvinas, Inc. | 2.24B | 1.71% | 274,651 | 71.30M |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.22B | -5.15% | 883,989 | - |
| 73 | KYMR | Kymera Therapeutics, Inc. | 2.17B | -0.53% | 225,604 | 79.41M |
| 74 | ADMA | ADMA Biologics, Inc. | 2.14B | 2.04% | 2,376,240 | 283.18M |
| 75 | RCKT | Rocket Pharmaceuticals, Inc. | 2.06B | -2.97% | 206,471 | - |
| 76 | BEAM | Beam Therapeutics Inc. | 2.01B | 2.56% | 423,944 | 360.91M |
| 77 | CGON | CG Oncology, Inc. | 1.99B | -3.78% | 342,981 | 539.00K |
| 78 | CPRX | Catalyst Pharmaceuticals, Inc. | 1.97B | 1.62% | 525,441 | 411.35M |
| 79 | GLPG | Galapagos NV | 1.95B | 0.17% | 109,060 | - |
| 80 | AGIO | Agios Pharmaceuticals, Inc. | 1.94B | -2.51% | 267,352 | 29.40M |
| 81 | ZLAB | Zai Lab Limited | 1.91B | -2.58% | 218,149 | 291.07M |
| 82 | SANA | Sana Biotechnology, Inc. | 1.91B | 0.58% | 505,669 | - |
| 83 | KROS | Keros Therapeutics, Inc. | 1.89B | -2.93% | 130,015 | 234.00K |
| 84 | NVAX | Novavax, Inc. | 1.85B | -8.68% | 10,086,084 | 996.61M |
| 85 | FUSN | Fusion Pharmaceuticals Inc. | 1.83B | 0.16% | 118,821 | 2.04M |
| 86 | ARDX | Ardelyx, Inc. | 1.81B | -0.51% | 1,219,098 | 159.11M |
| 87 | INBX | Inhibrx, Inc. | 1.81B | 0.35% | 522,067 | 1.78M |
| 88 | PTGX | Protagonist Therapeutics, Inc. | 1.81B | -3.13% | 180,121 | 314.95M |
| 89 | DNA | Ginkgo Bioworks Holdings, Inc. | 1.80B | -3.72% | 23,453,821 | 208.70M |
| 90 | NAMS | NewAmsterdam Pharma Company N.V. | 1.77B | -1.37% | 87,905 | - |
| 91 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | -2.37% | 427,507 | - |
| 92 | KURA | Kura Oncology, Inc. | 1.69B | -3.39% | 238,689 | - |
| 93 | EWTX | Edgewise Therapeutics, Inc. | 1.68B | -1.32% | 286,108 | - |
| 94 | SLNO | Soleno Therapeutics, Inc. | 1.67B | 0.84% | 197,687 | - |
| 95 | HRMY | Harmony Biosciences Holdings, Inc. | 1.66B | - | 177,793 | 617.51M |
| 96 | GPCR | Structure Therapeutics Inc. | 1.65B | -1.07% | 231,590 | - |
| 97 | LGND | Ligand Pharmaceuticals Incorporated | 1.54B | 0.89% | 51,819 | 118.31M |
| 98 | RCUS | Arcus Biosciences, Inc. | 1.54B | -3.15% | 144,862 | 237.00M |
| 99 | NMRA | Neumora Therapeutics, Inc. | 1.51B | -1.66% | 145,793 | - |
| 100 | SYRE | Spyre Therapeutics, Inc. | 1.51B | -0.70% | 213,133 | 688.00K |
| 101 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.50B | 2.07% | 1,027,466 | 274.10M |
| 102 | MORF | Morphic Holding, Inc. | 1.49B | -8.29% | 183,378 | - |
| 103 | XNCR | Xencor, Inc. | 1.42B | 2.58% | 317,909 | 162.18M |
| 104 | TARS | Tarsus Pharmaceuticals, Inc. | 1.41B | -2.90% | 205,024 | 42.56M |
| 105 | DAWN | Day One Biopharmaceuticals, Inc. | 1.41B | 1.06% | 160,853 | - |
| 106 | KNSA | Kiniksa Pharmaceuticals, Ltd. | 1.40B | -1.49% | 100,100 | 301.77M |
| 107 | AKRO | Akero Therapeutics, Inc. | 1.37B | -4.34% | 169,297 | - |
| 108 | CGEM | Cullinan Oncology, Inc. | 1.34B | -2.54% | 481,780 | - |
| 109 | BLTE | Belite Bio, Inc | 1.32B | 3.44% | 75,783 | - |
| 110 | VIR | Vir Biotechnology, Inc. | 1.31B | -3.07% | 220,903 | 79.60M |
| 111 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.30B | -2.94% | 1,947,326 | 355.40M |
| 112 | FDMT | 4D Molecular Therapeutics, Inc. | 1.28B | -3.63% | 201,908 | 20.45M |
| 113 | MNKD | MannKind Corporation | 1.25B | - | 951,291 | 224.60M |
| 114 | PRTA | Prothena Corporation plc | 1.21B | -3.72% | 178,976 | 89.25M |
| 115 | GYRE | Gyre Therapeutics, Inc. | 1.18B | -8.83% | 52,176 | 140.62M |
| 116 | MDXG | MiMedx Group, Inc. | 1.16B | -1.08% | 207,170 | 334.51M |
| 117 | MIRM | Mirum Pharmaceuticals, Inc. | 1.15B | -1.90% | 71,924 | 224.00M |
| 118 | IMTX | Immatics N.V. | 1.11B | -0.46% | 173,043 | 80.95M |
| 119 | PHVS | Pharvaris N.V. | 1.10B | -4.47% | 20,312 | - |
| 120 | SAVA | Cassava Sciences, Inc. | 1.10B | 6.52% | 570,757 | - |
| 121 | ELVN | Enliven Therapeutics, Inc. | 1.09B | -2.65% | 105,593 | - |
| 122 | ABCL | AbCellera Biologics Inc. | 1.07B | -3.57% | 746,807 | 35.79M |
| 123 | ARQT | Arcutis Biotherapeutics, Inc. | 1.06B | 0.44% | 2,187,852 | 106.39M |
| 124 | VRNA | Verona Pharma plc | 1.05B | -2.32% | 696,279 | - |
| 125 | SLN | Silence Therapeutics plc | 1.04B | -0.35% | 79,744 | 33.86M |
| 126 | INVA | Innoviva, Inc. | 1.00B | 0.41% | 149,674 | 311.59M |
| 127 | TYRA | Tyra Biosciences, Inc. | 970.25M | -3.19% | 78,005 | - |
| 128 | NRIX | Nurix Therapeutics, Inc. | 969.84M | 5.71% | 2,511,598 | 80.89M |
| 129 | LQDA | Liquidia Corporation | 960.51M | -1.10% | 377,631 | 15.97M |
| 130 | SRRK | Scholar Rock Holding Corporation | 953.06M | -16.13% | 1,240,632 | - |
| 131 | OCUL | Ocular Therapeutix, Inc. | 952.57M | -1.75% | 704,233 | 59.84M |
| 132 | PROK | ProKidney Corp. | 930.27M | 5.80% | 419,738 | - |
| 133 | PLRX | Pliant Therapeutics, Inc. | 922.98M | -2.31% | 251,241 | 248.00K |
| 134 | BCYC | Bicycle Therapeutics plc | 914.90M | -2.95% | 75,314 | 41.61M |
| 135 | CNTA | Centessa Pharmaceuticals plc | 895.29M | -0.34% | 44,834 | 6.85M |
| 136 | ABVX | Abivax SA | 880.84M | -0.71% | 12,949 | 5.13M |
| 137 | RLAY | Relay Therapeutics, Inc. | 876.10M | 1.38% | 929,112 | 35.33M |
| 138 | SPRY | ARS Pharmaceuticals, Inc. | 874.96M | -0.66% | 122,042 | 10.00K |
| 139 | VRDN | Viridian Therapeutics, Inc. | 873.09M | -6.56% | 693,950 | 288.00K |
| 140 | ETNB | 89bio, Inc. | 855.94M | -2.95% | 255,785 | - |
| 141 | ZNTL | Zentalis Pharmaceuticals, Inc. | 855.71M | 0.67% | 189,799 | 40.56M |
| 142 | PRME | Prime Medicine, Inc. | 849.82M | 0.28% | 418,209 | 591.00K |
| 143 | MESO | Mesoblast Limited | 835.39M | 4.56% | 153,992 | 7.25M |
| 144 | AUPH | Aurinia Pharmaceuticals Inc. | 828.80M | 0.52% | 1,289,791 | 191.41M |
| 145 | IMNM | Immunome, Inc. | 823.49M | -5.00% | 476,486 | 12.68M |
| 146 | NUVB | Nuvation Bio Inc. | 815.66M | -3.23% | 483,840 | - |
| 147 | CRGX | CARGO Therapeutics, Inc. | 807.06M | -4.36% | 71,251 | - |
| 148 | LBPH | Longboard Pharmaceuticals, Inc. | 803.07M | 0.54% | 89,597 | - |
| 149 | ARCT | Arcturus Therapeutics Holdings Inc. | 799.87M | -2.56% | 155,614 | 124.53M |
| 150 | IRON | Disc Medicine, Inc. | 794.80M | 0.53% | 99,957 | - |
| 151 | TNGX | Tango Therapeutics, Inc. | 793.33M | -4.75% | 144,773 | 37.23M |
| 152 | CVAC | CureVac N.V. | 786.95M | 0.72% | 1,946,033 | 59.73M |
| 153 | RGNX | REGENXBIO Inc. | 779.72M | -0.91% | 123,836 | 86.73M |
| 154 | HLVX | HilleVax, Inc. | 775.90M | 0.32% | 55,774 | - |
| 155 | PRTC | PureTech Health plc | 775.57M | 4.68% | 105 | 3.33M |
| 156 | PRAX | Praxis Precision Medicines, Inc. | 770.45M | -0.35% | 163,647 | 2.20M |
| 157 | WVE | Wave Life Sciences Ltd. | 764.15M | 5.93% | 501,760 | 112.91M |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 756.78M | -1.68% | 40,666 | 2.26M |
| 159 | AUTL | Autolus Therapeutics plc | 752.30M | 9.95% | 1,622,999 | 1.70M |
| 160 | ALXO | ALX Oncology Holdings Inc. | 749.20M | -1.98% | 81,927 | - |
| 161 | HUMA | Humacyte, Inc. | 737.13M | -3.50% | 2,935,337 | - |
| 162 | STOK | Stoke Therapeutics, Inc. | 722.12M | -1.25% | 277,540 | 7.85M |
| 163 | LYEL | Lyell Immunopharma, Inc. | 712.55M | 0.54% | 484,750 | 68.00K |
| 164 | SAGE | Sage Therapeutics, Inc. | 708.64M | -2.33% | 517,109 | 91.06M |
| 165 | COGT | Cogent Biosciences, Inc. | 708.50M | -0.80% | 286,512 | - |
| 166 | KYTX | Kyverna Therapeutics, Inc. | 679.71M | 2.79% | 170,850 | - |
| 167 | AVBP | ArriVent BioPharma, Inc. | 678.25M | 0.50% | 45,265 | - |
| 168 | ANAB | AnaptysBio, Inc. | 676.82M | -2.98% | 67,278 | 22.96M |
| 169 | GHRS | GH Research PLC | 656.07M | -0.24% | 37,331 | - |
| 170 | ITOS | iTeos Therapeutics, Inc. | 654.91M | 0.78% | 137,819 | - |
| 171 | EXAI | Exscientia plc | 648.52M | 0.39% | 461,637 | 25.42M |
| 172 | PHAR | Pharming Group N.V. | 643.14M | 2.14% | 968 | 280.83M |
| 173 | MLYS | Mineralys Therapeutics, Inc. | 641.46M | -2.43% | 20,174 | - |
| 174 | SVRA | Savara Inc. | 641.20M | -1.59% | 239,232 | - |
| 175 | ZYME | Zymeworks Inc. | 640.59M | -3.52% | 138,148 | 50.46M |
| 176 | EYPT | EyePoint Pharmaceuticals, Inc. | 628.14M | -3.83% | 502,302 | 50.02M |
| 177 | VALN | Valneva SE | 619.22M | 1.02% | 10,095 | 166.26M |
| 178 | ORIC | ORIC Pharmaceuticals, Inc. | 617.59M | 1.44% | 194,155 | - |
| 179 | PHAT | Phathom Pharmaceuticals, Inc. | 612.28M | -2.29% | 307,881 | 2.59M |
| 180 | ENGN | enGene Holdings Inc. | 602.64M | -3.70% | 3,758 | - |
| 181 | CABA | Cabaletta Bio, Inc. | 596.22M | -2.06% | 542,508 | - |
| 182 | AVTE | Aerovate Therapeutics, Inc. | 593.16M | -5.86% | 60,540 | - |
| 183 | CDMO | Avid Bioservices, Inc. | 591.31M | 0.76% | 1,255,855 | 136.74M |
| 184 | CALT | Calliditas Therapeutics AB (publ) | 588.25M | 1.32% | 740 | 119.73M |
| 185 | MNMD | Mind Medicine (MindMed) Inc. | 585.16M | -3.99% | 674,463 | - |
| 186 | TSHA | Taysha Gene Therapies, Inc. | 577.74M | -2.07% | 614,036 | 14.16M |
| 187 | ALT | Altimmune, Inc. | 568.49M | -9.78% | 2,428,983 | 410.00K |
| 188 | ABUS | Arbutus Biopharma Corporation | 560.49M | 2.77% | 586,836 | 12.99M |
| 189 | THRD | Third Harmonic Bio, Inc. | 560.41M | -3.44% | 25,050 | - |
| 190 | IGMS | IGM Biosciences, Inc. | 551.87M | 0.43% | 47,545 | 2.11M |
| 191 | OLMA | Olema Pharmaceuticals, Inc. | 547.59M | 1.55% | 266,205 | - |
| 192 | ADPT | Adaptive Biotechnologies Corporation | 527.80M | -3.49% | 1,026,775 | 174.50M |
| 193 | OABI | OmniAb, Inc. | 521.80M | -2.09% | 282,907 | 21.05M |
| 194 | ALEC | Alector, Inc. | 521.44M | -1.55% | 313,575 | 96.41M |
| 195 | ABSI | Absci Corporation | 519.13M | -3.16% | 364,221 | 5.35M |
| 196 | YMAB | Y-mAbs Therapeutics, Inc. | 515.49M | -0.84% | 206,188 | 84.50M |
| 197 | ATXS | Astria Therapeutics, Inc. | 513.99M | -0.85% | 108,499 | - |
| 198 | CBUS | Cibus, Inc. | 507.49M | -1.01% | 13,994 | 2.32M |
| 199 | CELC | Celcuity Inc. | 503.69M | -6.40% | 93,766 | - |
| 200 | TRDA | Entrada Therapeutics, Inc. | 501.66M | 0.27% | 71,917 | 162.87M |
| 201 | KALV | KalVista Pharmaceuticals, Inc. | 493.60M | -2.73% | 224,082 | - |
| 202 | HRTX | Heron Therapeutics, Inc. | 489.62M | 0.93% | 2,491,379 | 132.10M |
| 203 | OCGN | Ocugen, Inc. | 483.78M | -4.80% | 5,160,386 | 7.05M |
| 204 | APLT | Applied Therapeutics, Inc. | 482.21M | -0.47% | 330,833 | -477.00K |
| 205 | ALLO | Allogene Therapeutics, Inc. | 480.10M | -6.31% | 1,153,945 | 65.00K |
| 206 | URGN | UroGen Pharma Ltd. | 479.81M | 0.53% | 144,091 | 84.30M |
| 207 | TCRX | TScan Therapeutics, Inc. | 469.95M | -0.11% | 66,335 | 14.81M |
| 208 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 469.79M | -4.53% | 64,629 | - |
| 209 | RNAC | Cartesian Therapeutics, Inc. | 468.75M | 1.75% | 15,103 | 25.91M |
| 210 | FULC | Fulcrum Therapeutics, Inc. | 467.40M | -3.66% | 202,798 | 2.51M |
| 211 | VERV | Verve Therapeutics, Inc. | 466.97M | -6.90% | 1,255,015 | 16.05M |
| 212 | LRMR | Larimar Therapeutics, Inc. | 466.38M | -1.62% | 124,571 | - |
| 213 | NKTX | Nkarta, Inc. | 464.38M | -3.37% | 277,590 | - |
| 214 | EDIT | Editas Medicine, Inc. | 462.99M | -4.50% | 769,210 | 69.41M |
| 215 | TVTX | Travere Therapeutics, Inc. | 462.10M | -9.12% | 585,925 | 183.23M |
| 216 | LXEO | Lexeo Therapeutics, Inc. | 457.94M | -0.57% | 33,888 | - |
| 217 | VYGR | Voyager Therapeutics, Inc. | 454.19M | -3.24% | 312,629 | 119.04M |
| 218 | TBPH | Theravance Biopharma, Inc. | 451.78M | -2.40% | 132,772 | 61.51M |
| 219 | FATE | Fate Therapeutics, Inc. | 449.07M | -4.83% | 680,329 | 6.48M |
| 220 | BMEA | Biomea Fusion, Inc. | 443.20M | -3.29% | 208,185 | - |
| 221 | LXRX | Lexicon Pharmaceuticals, Inc. | 442.00M | -2.45% | 1,493,634 | 2.31M |
| 222 | MREO | Mereo BioPharma Group plc | 441.15M | -3.67% | 292,135 | - |
| 223 | OCS | Oculis Holding AG | 439.97M | -0.79% | 3,730 | 995.46K |
| 224 | SLRN | Acelyrin, Inc. | 436.21M | -5.18% | 471,829 | - |
| 225 | PEPG | PepGen Inc. | 435.69M | -1.83% | 19,251 | - |
| 226 | KRRO | Korro Bio, Inc. | 429.25M | 3.84% | 45,723 | - |
| 227 | NGNE | Neurogene Inc. | 422.12M | -2.83% | 26,305 | - |
| 228 | LENZ | LENZ Therapeutics, Inc. | 416.20M | -1.39% | 135,946 | - |
| 229 | REPL | Replimune Group, Inc. | 407.31M | -1.34% | 430,885 | - |
| 230 | ADCT | ADC Therapeutics SA | 392.60M | -0.49% | 232,597 | 68.62M |
| 231 | CCCC | C4 Therapeutics, Inc. | 388.75M | -5.36% | 618,859 | 20.04M |
| 232 | CTNM | Contineum Therapeutics, Inc. | 388.27M | 3.01% | 51,576 | 50.00M |
| 233 | TRML | Tourmaline Bio, Inc. | 388.03M | 0.47% | 118,091 | - |
| 234 | ANNX | Annexon, Inc. | 385.98M | -2.87% | 953,187 | - |
| 235 | TERN | Terns Pharmaceuticals, Inc. | 384.18M | -3.09% | 195,284 | - |
| 236 | STTK | Shattuck Labs, Inc. | 383.26M | 2.61% | 403,086 | 2.72M |
| 237 | AVXL | Anavex Life Sciences Corp. | 382.16M | 0.33% | 468,853 | - |
| 238 | VRCA | Verrica Pharmaceuticals Inc. | 379.02M | -1.97% | 98,599 | 8.91M |
| 239 | NAUT | Nautilus Biotechnology, Inc. | 368.91M | 0.68% | 73,081 | - |
| 240 | FBLG | FibroBiologics, Inc. | 366.46M | -3.86% | 39,720 | - |
| 241 | MGTX | MeiraGTx Holdings plc | 364.62M | -0.09% | 41,543 | 697.00K |
| 242 | QTTB | Q32 Bio Inc. | 360.95M | -0.81% | 31,510 | 354.00K |
| 243 | PGEN | Precigen, Inc. | 355.91M | 1.07% | 391,640 | 5.44M |
| 244 | AURA | Aura Biosciences, Inc. | 354.23M | -0.83% | 140,269 | - |
| 245 | IMMP | Immutep Limited | 353.08M | 1.71% | 98,610 | 4.58M |
| 246 | TNYA | Tenaya Therapeutics, Inc. | 351.76M | 5.41% | 444,726 | - |
| 247 | ERAS | Erasca, Inc. | 347.58M | 8.11% | 5,229,588 | - |
| 248 | JSPR | Jasper Therapeutics, Inc. | 345.76M | 0.33% | 47,247 | - |
| 249 | CADL | Candel Therapeutics, Inc. | 342.36M | -9.45% | 649,905 | - |
| 250 | SKYE | Skye Bioscience, Inc. | 339.62M | -1.22% | 16,074 | - |
| 251 | NBTX | Nanobiotix S.A. | 338.73M | -0.83% | 1,253 | 40.23M |
| 252 | ANRO | Alto Neuroscience, Inc. | 334.71M | -2.89% | 43,727 | - |
| 253 | SLDB | Solid Biosciences Inc. | 334.69M | -4.89% | 167,661 | - |
| 254 | STRO | Sutro Biopharma, Inc. | 333.72M | -1.69% | 258,435 | 154.07M |
| 255 | MRSN | Mersana Therapeutics, Inc. | 332.21M | 5.04% | 1,262,645 | 38.30M |
| 256 | VTYX | Ventyx Biosciences, Inc. | 326.41M | -7.03% | 287,810 | - |
| 257 | VNDA | Vanda Pharmaceuticals Inc. | 319.80M | -1.52% | 557,256 | 177.60M |
| 258 | RVNC | Revance Therapeutics, Inc. | 319.61M | -3.32% | 1,354,832 | 236.65M |
| 259 | NKTR | Nektar Therapeutics | 318.59M | -4.17% | 635,644 | 90.17M |
| 260 | PSTX | Poseida Therapeutics, Inc. | 315.60M | -2.69% | 353,834 | 82.50M |
| 261 | GUTS | Fractyl Health, Inc. | 313.25M | -1.94% | 154,291 | 148.00K |
| 262 | ACIU | AC Immune SA | 308.51M | -8.36% | 463,280 | 16.82M |
| 263 | INO | Inovio Pharmaceuticals, Inc. | 308.34M | -6.96% | 317,601 | 717.07K |
| 264 | AVIR | Atea Pharmaceuticals, Inc. | 307.41M | -1.22% | 185,135 | - |
| 265 | CRBU | Caribou Biosciences, Inc. | 307.08M | -5.29% | 1,856,535 | 33.40M |
| 266 | XOMA | XOMA Corporation | 299.81M | 0.39% | 3,984 | 5.81M |
| 267 | XERS | Xeris Biopharma Holdings, Inc. | 295.03M | -1.49% | 975,604 | 171.36M |
| 268 | ATAI | Atai Life Sciences N.V. | 292.14M | -5.91% | 1,910,503 | 277.00K |
| 269 | VSTM | Verastem, Inc. | 291.60M | -4.95% | 94,402 | - |
| 270 | IVVD | Invivyd, Inc. | 286.36M | -2.24% | 218,462 | - |
| 271 | ADAP | Adaptimmune Therapeutics plc | 286.13M | -7.50% | 842,093 | 18.36M |
| 272 | ATNM | Actinium Pharmaceuticals, Inc. | 284.43M | -3.05% | 122,348 | 81.00K |
| 273 | INZY | Inozyme Pharma, Inc. | 284.23M | -2.75% | 168,648 | - |
| 274 | OPT | Opthea Limited | 281.69M | -2.02% | 7,224 | 385.28K |
| 275 | BDTX | Black Diamond Therapeutics, Inc. | 281.26M | -3.53% | 993,240 | - |
| 276 | CRMD | CorMedix Inc. | 280.28M | -1.73% | 329,785 | - |
| 277 | MGNX | MacroGenics, Inc. | 279.03M | -12.89% | 2,419,366 | 43.36M |
| 278 | RANI | Rani Therapeutics Holdings, Inc. | 274.10M | -0.44% | 101,938 | - |
| 279 | ZURA | Zura Bio Limited | 269.85M | 3.50% | 238,111 | - |
| 280 | EPIX | ESSA Pharma Inc. | 268.40M | -4.16% | 12,122 | - |
| 281 | ACRV | Acrivon Therapeutics, Inc. | 267.09M | 0.64% | 34,726 | - |
| 282 | GLUE | Monte Rosa Therapeutics, Inc. | 266.45M | 1.05% | 86,169 | 1.06M |
| 283 | ENTA | Enanta Pharmaceuticals, Inc. | 263.68M | -4.75% | 138,938 | 72.88M |
| 284 | CYBN | Cybin Inc. | 261.79M | -2.39% | 1,299,638 | - |
| 285 | MGX | Metagenomi, Inc. | 261.18M | -0.07% | 13,690 | 47.26M |
| 286 | XBIT | XBiotech Inc. | 257.98M | -2.10% | 12,808 | - |
| 287 | CDXC | ChromaDex Corporation | 253.81M | -3.45% | 141,808 | 83.17M |
| 288 | CDXS | Codexis, Inc. | 253.65M | -4.64% | 316,086 | 74.23M |
| 289 | QSI | Quantum-Si incorporated | 251.02M | -5.11% | 208,274 | 1.29M |
| 290 | IPSC | Century Therapeutics, Inc. | 248.96M | -3.99% | 44,958 | 1.37M |
| 291 | DSGN | Design Therapeutics, Inc. | 248.30M | -2.44% | 85,656 | - |
| 292 | CHRS | Coherus BioSciences, Inc. | 244.94M | -1.15% | 1,073,792 | 301.87M |
| 293 | PYXS | Pyxis Oncology, Inc. | 244.68M | - | 182,802 | 16.15M |
| 294 | QURE | uniQure N.V. | 243.96M | -0.89% | 256,774 | 19.00M |
| 295 | GBIO | Generation Bio Co. | 242.83M | -2.39% | 51,646 | 9.96M |
| 296 | TSVT | 2seventy bio, Inc. | 242.63M | -5.40% | 145,259 | 71.20M |
| 297 | AKBA | Akebia Therapeutics, Inc. | 241.04M | 0.88% | 1,780,709 | 187.23M |
| 298 | FHTX | Foghorn Therapeutics Inc. | 238.05M | -4.82% | 23,425 | 33.90M |
| 299 | GTHX | G1 Therapeutics, Inc. | 236.73M | -3.21% | 401,435 | 84.04M |
| 300 | ALDX | Aldeyra Therapeutics, Inc. | 235.88M | -2.93% | 143,374 | - |
| 301 | ELYM | Eliem Therapeutics, Inc. | 235.65M | 3.91% | 264,443 | - |
| 302 | AGEN | Agenus Inc. | 230.57M | 4.00% | 326,254 | 161.42M |
| 303 | ANL | Adlai Nortye Ltd. | 226.29M | -4.81% | 1,559 | 5.00M |
| 304 | PRLD | Prelude Therapeutics Incorporated | 225.21M | -4.21% | 30,194 | - |
| 305 | OVID | Ovid Therapeutics Inc. | 221.35M | -4.12% | 44,423 | 473.54K |
| 306 | MACK | Merrimack Pharmaceuticals, Inc. | 220.08M | 0.10% | 526,898 | - |
| 307 | IPHA | Innate Pharma S.A. | 219.07M | 3.89% | 12,028 | 68.49M |
| 308 | CMPX | Compass Therapeutics, Inc. | 218.77M | -0.31% | 105,583 | - |
| 309 | INMB | INmune Bio, Inc. | 217.80M | -1.21% | 47,569 | 131.00K |
| 310 | ABOS | Acumen Pharmaceuticals, Inc. | 217.79M | -2.68% | 47,307 | - |
| 311 | CDT | Conduit Pharmaceuticals Inc. | 215.58M | 2.04% | 10,987 | - |
| 312 | CLLS | Cellectis S.A. | 213.43M | -1.82% | 21,207 | 9.19M |
| 313 | BOLD | Boundless Bio, Inc. | 212.31M | -4.12% | 38,340 | - |
| 314 | PBYI | Puma Biotechnology, Inc. | 210.32M | - | 416,341 | 226.63M |
| 315 | HOWL | Werewolf Therapeutics, Inc. | 209.46M | -1.43% | 87,022 | 16.22M |
| 316 | BLUE | bluebird bio, Inc. | 202.38M | -0.48% | 1,288,400 | 21.73M |
| 317 | GALT | Galectin Therapeutics Inc. | 201.19M | 3.34% | 96,741 | - |
| 318 | CRVO | CervoMed Inc. | 199.25M | -0.04% | 11,762 | 6.36M |
| 319 | CAPR | Capricor Therapeutics, Inc. | 198.50M | 10.73% | 547,669 | 27.10M |
| 320 | IVA | Inventiva S.A. | 197.70M | 2.30% | 7,111 | 25.74M |
| 321 | ELEV | Elevation Oncology, Inc. | 196.70M | -0.28% | 109,198 | - |
| 322 | ZVRA | Zevra Therapeutics, Inc. | 196.29M | -1.47% | 78,293 | 28.01M |
| 323 | TRVI | Trevi Therapeutics, Inc. | 195.81M | -2.82% | 44,171 | - |
| 324 | ATOS | Atossa Therapeutics, Inc. | 195.55M | -3.11% | 637,368 | - |
| 325 | LCTX | Lineage Cell Therapeutics, Inc. | 195.41M | -2.83% | 840,605 | 8.00M |
| 326 | OMER | Omeros Corporation | 193.82M | 1.06% | 262,732 | - |
| 327 | OBIO | Orchestra BioMed Holdings, Inc. | 193.26M | 16.45% | 27,008 | 2.22M |
| 328 | DRTS | Alpha Tau Medical Ltd. | 190.83M | 4.56% | 29,727 | - |
| 329 | VERU | Veru Inc. | 187.59M | -6.57% | 1,210,674 | 13.48M |
| 330 | CGEN | Compugen Ltd. | 187.23M | -1.87% | 157,455 | 33.46M |
| 331 | FENC | Fennec Pharmaceuticals Inc. | 186.61M | -4.07% | 198,393 | 44.95M |
| 332 | ABEO | Abeona Therapeutics Inc. | 184.72M | -2.61% | 362,279 | 3.50M |
| 333 | GNFT | Genfit S.A. | 184.70M | -2.24% | 5,923 | 42.42M |
| 334 | YS | YS Biopharma Co., Ltd. | 183.62M | 2.63% | 45,505 | - |
| 335 | GLSI | Greenwich LifeSciences, Inc. | 181.33M | -1.18% | 13,103 | - |
| 336 | OTLK | Outlook Therapeutics, Inc. | 179.29M | 4.64% | 130,635 | - |
| 337 | TELO | Telomir Pharmaceuticals, Inc. | 178.55M | -4.66% | 17,841 | - |
| 338 | KOD | Kodiak Sciences Inc. | 175.43M | -10.56% | 357,873 | - |
| 339 | ACHV | Achieve Life Sciences, Inc. | 170.68M | -1.97% | 49,846 | - |
| 340 | SCPH | scPharmaceuticals Inc. | 170.54M | -1.76% | 138,749 | 17.63M |
| 341 | VXRT | Vaxart, Inc. | 170.14M | -5.07% | 1,210,199 | 8.89M |
| 342 | ADVM | Adverum Biotechnologies, Inc. | 167.61M | -2.67% | 368,429 | - |
| 343 | RIGL | Rigel Pharmaceuticals, Inc. | 167.25M | -2.80% | 239,677 | 120.35M |
| 344 | CRDF | Cardiff Oncology, Inc. | 163.69M | -2.41% | 238,935 | 610.00K |
| 345 | MDWD | MediWound Ltd. | 163.59M | -0.12% | 11,073 | 18.69M |
| 346 | GOSS | Gossamer Bio, Inc. | 158.44M | -3.42% | 678,883 | - |
| 347 | PRQR | ProQR Therapeutics N.V. | 156.38M | 0.52% | 59,059 | 14.66M |
| 348 | XFOR | X4 Pharmaceuticals, Inc. | 154.77M | -5.86% | 1,497,910 | - |
| 349 | RPTX | Repare Therapeutics Inc. | 152.38M | 1.70% | 168,494 | 97.86M |
| 350 | CNTX | Context Therapeutics Inc. | 150.00M | 11.11% | 536,141 | - |
| 351 | CTMX | CytomX Therapeutics, Inc. | 149.99M | -4.00% | 2,686,419 | 119.18M |
| 352 | SGMT | Sagimet Biosciences Inc. | 146.17M | -3.37% | 209,370 | 2.00M |
| 353 | SYRS | Syros Pharmaceuticals, Inc. | 144.87M | -0.91% | 124,185 | 6.98M |
| 354 | CRVS | Corvus Pharmaceuticals, Inc. | 143.32M | 4.34% | 202,092 | - |
| 355 | SGMO | Sangamo Therapeutics, Inc. | 142.37M | 13.36% | 4,080,561 | 18.76M |
| 356 | RAPT | RAPT Therapeutics, Inc. | 141.88M | -1.93% | 313,784 | - |
| 357 | MCRB | Seres Therapeutics, Inc. | 140.35M | -0.22% | 1,474,027 | 126.85M |
| 358 | BCAB | BioAtla, Inc. | 139.35M | -5.97% | 398,801 | - |
| 359 | LIFE | aTyr Pharma, Inc. | 137.68M | 3.11% | 502,356 | 588.00K |
| 360 | IMAB | I-Mab | 134.79M | -1.41% | 225,251 | 3.90M |
| 361 | SEER | Seer, Inc. | 134.42M | -2.36% | 214,593 | 15.67M |
| 362 | KPTI | Karyopharm Therapeutics Inc. | 133.60M | - | 1,287,805 | 140.46M |
| 363 | OMGA | Omega Therapeutics, Inc. | 133.48M | 0.63% | 177,295 | 4.94M |
| 364 | VIGL | Vigil Neuroscience, Inc. | 131.92M | -0.42% | 33,081 | - |
| 365 | TVGN | Tevogen Bio Holdings Inc. | 131.71M | -10.10% | 355,840 | - |
| 366 | ACET | Adicet Bio, Inc. | 131.48M | 1.59% | 741,662 | - |
| 367 | RENB | Renovaro Biosciences Inc. | 130.44M | -1.83% | 102,019 | - |
| 368 | PDSB | PDS Biotechnology Corporation | 129.11M | -0.14% | 157,177 | - |
| 369 | RGLS | Regulus Therapeutics Inc. | 128.31M | -1.00% | 197,339 | - |
| 370 | COYA | Coya Therapeutics, Inc. | 127.91M | 2.24% | 37,169 | 6.13M |
| 371 | DBVT | DBV Technologies S.A. | 127.57M | -1.30% | 107,230 | 14.94M |
| 372 | ALLK | Allakos Inc. | 126.62M | -1.38% | 232,201 | - |
| 373 | MOLN | Molecular Partners AG | 125.43M | 1.61% | 523 | 8.38M |
| 374 | AMLX | Amylyx Pharmaceuticals, Inc. | 124.62M | 0.55% | 676,711 | 398.00M |
| 375 | FGEN | FibroGen, Inc. | 124.34M | 0.40% | 908,736 | 167.49M |
| 376 | VOR | Vor Biopharma Inc. | 124.23M | 0.83% | 131,284 | - |
| 377 | VTGN | VistaGen Therapeutics, Inc. | 121.07M | -1.87% | 49,510 | 1.04M |
| 378 | DMAC | DiaMedica Therapeutics Inc. | 120.35M | - | 5,623 | - |
| 379 | CTXR | Citius Pharmaceuticals, Inc. | 119.19M | -1.17% | 626,348 | - |
| 380 | CLRB | Cellectar Biosciences, Inc. | 118.30M | -0.30% | 539,811 | - |
| 381 | NVCT | Nuvectis Pharma, Inc. | 116.56M | -3.60% | 48,588 | - |
| 382 | IMUX | Immunic, Inc. | 109.03M | -2.80% | 1,324,396 | - |
| 383 | VANI | Vivani Medical, Inc. | 108.31M | - | 113,828 | - |
| 384 | ADAG | Adagene Inc. | 107.20M | -0.61% | 4,956 | 18.11M |
| 385 | PMVP | PMV Pharmaceuticals, Inc. | 106.75M | -3.49% | 101,910 | - |
| 386 | BYSI | BeyondSpring Inc. | 105.73M | -4.41% | 38,993 | 1.75M |
| 387 | EPRX | Eupraxia Pharmaceuticals Inc. | 104.73M | - | 3,912 | - |
| 388 | RZLT | Rezolute, Inc. | 103.93M | 1.37% | 192,028 | - |
| 389 | ELTX | Elicio Therapeutics, Inc. | 102.93M | 7.25% | 42,416 | - |
| 390 | LPTX | Leap Therapeutics, Inc. | 102.93M | -4.38% | 336,419 | - |
| 391 | RLMD | Relmada Therapeutics, Inc. | 102.59M | -2.58% | 35,869 | - |
| 392 | GNLX | Genelux Corporation | 99.89M | 2.36% | 27,674 | 8.00K |
| 393 | CLSD | Clearside Biomedical, Inc. | 98.83M | 0.76% | 131,827 | 8.45M |
| 394 | CNTB | Connect Biopharma Holdings Limited | 98.36M | 0.85% | 34,067 | - |
| 395 | ARMP | Armata Pharmaceuticals, Inc. | 97.62M | 1.89% | 21,107 | 4.70M |
| 396 | ATHA | Athira Pharma, Inc. | 94.86M | -8.86% | 115,252 | - |
| 397 | IFRX | InflaRx N.V. | 94.80M | 10.34% | 423,333 | 107.75K |
| 398 | ORMP | Oramed Pharmaceuticals Inc. | 94.67M | - | 32,627 | 674.00K |
| 399 | MIST | Milestone Pharmaceuticals Inc. | 92.94M | - | 233,886 | - |
| 400 | IOBT | IO Biotech, Inc. | 91.57M | -1.07% | 36,431 | - |
| 401 | BRNS | Barinthus Biotherapeutics plc | 91.54M | -3.29% | 353 | 334.00K |
| 402 | ANIX | Anixa Biosciences, Inc. | 91.07M | -1.37% | 62,900 | 210.00K |
| 403 | CMRX | Chimerix, Inc. | 89.26M | 2.08% | 62,300 | 41.00K |
| 404 | BNTC | Benitec Biopharma Inc. | 88.90M | -1.16% | 22,290 | 7.00K |
| 405 | ALVR | AlloVir, Inc. | 88.40M | 2.48% | 100,688 | - |
| 406 | ANVS | Annovis Bio, Inc. | 87.64M | -2.37% | 298,710 | - |
| 407 | GRTS | Gritstone bio, Inc. | 86.32M | 6.30% | 1,508,658 | 15.65M |
| 408 | ENTX | Entera Bio Ltd. | 86.24M | -7.31% | 60,591 | - |
| 409 | SLS | SELLAS Life Sciences Group, Inc. | 84.90M | 0.34% | 851,880 | - |
| 410 | DTIL | Precision BioSciences, Inc. | 84.56M | 1.92% | 29,458 | 57.53M |
| 411 | ONCY | Oncolytics Biotech Inc. | 84.37M | -1.77% | 193,385 | - |
| 412 | SPRO | Spero Therapeutics, Inc. | 84.34M | 0.64% | 68,209 | 110.98M |
| 413 | PLX | Protalix BioTherapeutics, Inc. | 83.95M | -2.14% | 118,568 | 59.65M |
| 414 | PASG | Passage Bio, Inc. | 83.21M | 0.75% | 33,162 | - |
| 415 | CUE | Cue Biopharma, Inc. | 82.21M | -2.87% | 63,845 | 7.02M |
| 416 | ALRN | Aileron Therapeutics, Inc. | 82.04M | -1.82% | 15,833 | - |
| 417 | ASMB | Assembly Biosciences, Inc. | 81.79M | 0.88% | 5,180 | - |
| 418 | AFMD | Affimed N.V. | 80.71M | -3.49% | 16,089 | 9.19M |
| 419 | BTAI | BioXcel Therapeutics, Inc. | 80.13M | 1.91% | 651,345 | 1.76M |
| 420 | HOOK | HOOKIPA Pharma Inc. | 79.66M | 2.34% | 209,256 | 53.55M |
| 421 | CGTX | Cognition Therapeutics, Inc. | 78.92M | 1.55% | 47,694 | - |
| 422 | TIL | Instil Bio, Inc. | 76.68M | 0.68% | 523 | - |
| 423 | JAGX | Jaguar Health, Inc. | 76.11M | -7.53% | 20,615,811 | 10.14M |
| 424 | TLSA | Tiziana Life Sciences Ltd | 75.68M | 5.78% | 99,320 | - |
| 425 | RLYB | Rallybio Corporation | 74.99M | -2.69% | 122,011 | - |
| 426 | ATRA | Atara Biotherapeutics, Inc. | 74.67M | 2.72% | 971,940 | 34.70M |
| 427 | MAIA | MAIA Biotechnology, Inc. | 73.81M | 8.30% | 361,817 | - |
| 428 | MRNS | Marinus Pharmaceuticals, Inc. | 72.79M | 1.54% | 901,454 | 28.29M |
| 429 | CLGN | CollPlant Biotechnologies Ltd. | 72.74M | -0.78% | 1,836 | 10.96M |
| 430 | ELDN | Eledon Pharmaceuticals, Inc. | 71.63M | 11.79% | 549,289 | - |
| 431 | CVM | CEL-SCI Corporation | 71.25M | -6.07% | 217,442 | - |
| 432 | TPST | Tempest Therapeutics, Inc. | 70.65M | -1.55% | 277,643 | - |
| 433 | LVTX | LAVA Therapeutics N.V. | 70.45M | -2.17% | 30,455 | 7.52M |
| 434 | LABP | Landos Biopharma, Inc. | 70.24M | - | 5,739 | - |
| 435 | MNOV | MediciNova, Inc. | 69.89M | -0.35% | 5,382 | 1.00M |
| 436 | CRIS | Curis, Inc. | 69.15M | -6.89% | 23,825 | 9.81M |
| 437 | IKNA | Ikena Oncology, Inc. | 69.01M | 1.50% | 102,950 | 3.85M |
| 438 | CKPT | Checkpoint Therapeutics, Inc. | 68.87M | 6.46% | 363,575 | 68.00K |
| 439 | SER | Serina Therapeutics Inc | 68.62M | 0.37% | 3,026 | 3.15M |
| 440 | INTS | Intensity Therapeutics, Inc. | 68.41M | -2.18% | 40,401 | - |
| 441 | VTVT | vTv Therapeutics Inc. | 67.83M | -4.63% | 5,573 | 1.00M |
| 442 | ANTX | AN2 Therapeutics, Inc. | 67.41M | - | 34,941 | - |
| 443 | CELU | Celularity Inc. | 67.03M | -0.33% | 27,134 | 14.79M |
| 444 | LTRN | Lantern Pharma Inc. | 66.70M | 0.98% | 39,815 | - |
| 445 | CSBR | Champions Oncology, Inc. | 64.71M | 1.28% | 1,366 | 49.22M |
| 446 | MURA | Mural Oncology plc | 64.06M | -2.31% | 62,212 | - |
| 447 | TARA | Protara Therapeutics, Inc. | 63.62M | -17.25% | 547,107 | - |
| 448 | IMMX | Immix Biopharma, Inc. | 63.53M | 6.89% | 85,936 | - |
| 449 | TSBX | Turnstone Biologics Corp. | 61.98M | -2.56% | 59,252 | 19.31M |
| 450 | AVRO | AVROBIO, Inc. | 61.06M | -2.16% | 499,330 | - |
| 451 | KRON | Kronos Bio, Inc. | 60.35M | 2.36% | 215,796 | 7.59M |
| 452 | OCEA | Ocean Biomedical, Inc. | 60.29M | 2.94% | 99,287 | - |
| 453 | GNTA | Genenta Science S.p.A. | 60.12M | - | 1,675 | - |
| 454 | AEON | AEON Biopharma, Inc. | 59.86M | 1.00% | 59,128 | - |
| 455 | ANEB | Anebulo Pharmaceuticals, Inc. | 59.64M | 4.55% | 7,122 | - |
| 456 | CARM | Carisma Therapeutics, Inc. | 57.01M | 0.22% | 181,645 | 15.07M |
| 457 | THTX | Theratechnologies Inc. | 56.83M | -5.38% | 18,785 | 57.85M |
| 458 | RPHM | Reneo Pharmaceuticals, Inc. | 56.65M | 1.81% | 116,782 | - |
| 459 | KZR | Kezar Life Sciences, Inc. | 55.91M | 0.20% | 137,138 | 7.00M |
| 460 | EQ | Equillium, Inc. | 55.67M | 1.30% | 25,889 | 37.89M |
| 461 | BLRX | BioLineRx Ltd. | 53.10M | 1.26% | 279,671 | 4.80M |
| 462 | ALGS | Aligos Therapeutics, Inc. | 52.41M | 6.87% | 795,536 | 13.79M |
| 463 | CDTX | Cidara Therapeutics, Inc. | 51.04M | -6.77% | 55,997 | 46.38M |
| 464 | DYAI | Dyadic International, Inc. | 50.43M | 3.92% | 16,309 | 2.26M |
| 465 | CLNN | Clene Inc. | 49.42M | -0.21% | 250,923 | 620.00K |
| 466 | NTRB | Nutriband Inc. | 48.82M | -4.66% | 38,209 | 2.09M |
| 467 | NXTC | NextCure, Inc. | 48.70M | 3.94% | 77,891 | - |
| 468 | OKYO | OKYO Pharma Limited | 48.56M | -1.94% | 11,776 | - |
| 469 | CTCX | Carmell Therapeutics Corporation | 48.01M | 11.88% | 21,955 | 21.92M |
| 470 | ABIO | ARCA biopharma, Inc. | 47.73M | -17.25% | 402,232 | - |
| 471 | DARE | Daré Bioscience, Inc. | 47.50M | 8.05% | 782,914 | 2.82M |
| 472 | GANX | Gain Therapeutics, Inc. | 46.94M | -2.42% | 46,562 | - |
| 473 | AADI | Aadi Bioscience, Inc. | 46.65M | -0.78% | 60,921 | 23.84M |
| 474 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 46.09M | -2.92% | 267,197 | - |
| 475 | INAB | IN8bio, Inc. | 45.89M | 0.98% | 28,316 | - |
| 476 | MLEC | Moolec Science SA | 45.45M | 0.83% | 37,936 | 2.90M |
| 477 | IMRX | Immuneering Corporation | 45.13M | -0.65% | 67,790 | - |
| 478 | OCUP | Ocuphire Pharma, Inc. | 44.33M | 0.29% | 93,040 | 19.01M |
| 479 | CASI | CASI Pharmaceuticals, Inc. | 43.29M | -1.98% | 13,026 | 33.88M |
| 480 | MTNB | Matinas BioPharma Holdings, Inc. | 42.94M | -1.04% | 1,336,521 | - |
| 481 | EYEN | Eyenovia, Inc. | 42.83M | -3.14% | 739,535 | 8.78K |
| 482 | XLO | Xilio Therapeutics, Inc. | 42.45M | 7.41% | 94,649 | - |
| 483 | HCWB | HCW Biologics Inc. | 42.36M | - | 12,737 | 1.16M |
| 484 | CARA | Cara Therapeutics, Inc. | 42.24M | -3.96% | 187,154 | 16.94M |
| 485 | VYNE | VYNE Therapeutics Inc. | 40.24M | 2.96% | 18,268 | 423.00K |
| 486 | ESLA | Estrella Immunopharma, Inc. | 39.91M | 5.83% | 23,947 | - |
| 487 | LEXX | Lexaria Bioscience Corp. | 39.82M | -1.59% | 225,879 | 386.00K |
| 488 | QNCX | Quince Therapeutics, Inc. | 39.33M | -1.22% | 159,995 | - |
| 489 | UNCY | Unicycive Therapeutics, Inc. | 39.30M | 1.46% | 126,522 | - |
| 490 | ACHL | Achilles Therapeutics plc | 39.00M | 1.18% | 100,241 | - |
| 491 | SNSE | Sensei Biotherapeutics, Inc. | 38.12M | -3.46% | 162,092 | - |
| 492 | IGC | IGC Pharma Inc | 38.08M | -5.99% | 767,642 | 1.22M |
| 493 | ICCC | ImmuCell Corporation | 37.89M | - | 25,095 | 21.28M |
| 494 | NRXP | NRx Pharmaceuticals, Inc. | 37.39M | -1.99% | 170,629 | - |
| 495 | MRKR | Marker Therapeutics, Inc. | 37.22M | 4.68% | 6,746 | 3.32M |
| 496 | BCLI | Brainstorm Cell Therapeutics Inc. | 37.14M | 0.85% | 579,843 | - |
| 497 | FBIO | Fortress Biotech, Inc. | 35.97M | 5.11% | 253,138 | 85.11M |
| 498 | ACXP | Acurx Pharmaceuticals, Inc. | 35.57M | 3.67% | 31,494 | - |
| 499 | INKT | MiNK Therapeutics, Inc. | 35.42M | -1.92% | 59,802 | - |
| 500 | SABS | SAB Biotherapeutics, Inc. | 34.96M | -0.26% | 10,281 | 2.24M |
| 501 | PMN | ProMIS Neurosciences, Inc. | 34.68M | 0.92% | 5,658 | - |
| 502 | RNXT | RenovoRx, Inc. | 34.29M | 0.85% | 27,705 | - |
| 503 | PTN | Palatin Technologies, Inc. | 33.24M | 0.25% | 81,339 | 5.90M |
| 504 | VIRX | Viracta Therapeutics, Inc. | 32.98M | 3.68% | 65,646 | - |
| 505 | LPCN | Lipocine Inc. | 32.89M | 6.97% | 41,043 | 4.71M |
| 506 | EVGN | Evogene Ltd. | 32.63M | -0.80% | 37,696 | 5.64M |
| 507 | PLUR | Pluri Inc. | 32.44M | -1.96% | 4,582 | 341.00K |
| 508 | IPA | ImmunoPrecise Antibodies Ltd. | 32.10M | 9.91% | 149,661 | 17.67M |
| 509 | SPRB | Spruce Biosciences, Inc. | 30.95M | -2.75% | 401,570 | 10.13M |
| 510 | BOLT | Bolt Biotherapeutics, Inc. | 30.82M | -1.70% | 403,690 | 11.32M |
| 511 | SRZN | Surrozen, Inc. | 30.07M | -4.14% | 6,767 | - |
| 512 | BIVI | BioVie Inc. | 30.00M | -1.66% | 193,634 | - |
| 513 | APLM | Apollomics, Inc. | 29.73M | -2.29% | 65,030 | - |
| 514 | APRE | Aprea Therapeutics, Inc. | 29.43M | -2.75% | 7,315 | 963.80K |
| 515 | ICU | SeaStar Medical Holding Corporation | 29.39M | -2.49% | 955,534 | - |
| 516 | ENLV | Enlivex Therapeutics Ltd. | 26.60M | 2.14% | 22,012 | - |
| 517 | BIOR | Biora Therapeutics, Inc. | 26.37M | 0.23% | 183,832 | 544.00K |
| 518 | ONCT | Oncternal Therapeutics, Inc. | 25.45M | -2.60% | 1,545 | 1.15M |
| 519 | ACST | Acasti Pharma Inc. | 25.42M | -1.64% | 13,867 | - |
| 520 | NKGN | NKGen Biotech, Inc. | 25.19M | -0.88% | 41,702 | - |
| 521 | APM | Aptorum Group Limited | 25.08M | -5.10% | 19,435 | 431.38K |
| 522 | UBX | Unity Biotechnology, Inc. | 24.93M | 1.29% | 33,997 | - |
| 523 | GDTC | CytoMed Therapeutics Limited | 24.58M | -0.47% | 5,246 | - |
| 524 | NNVC | NanoViricides, Inc. | 24.47M | -7.17% | 202,690 | - |
| 525 | ITRM | Iterum Therapeutics plc | 24.00M | -0.68% | 76,126 | - |
| 526 | LYRA | Lyra Therapeutics, Inc. | 23.44M | 4.57% | 4,856,399 | 1.68M |
| 527 | LSTA | Lisata Therapeutics, Inc. | 22.72M | 0.18% | 8,473 | - |
| 528 | NRBO | NeuroBo Pharmaceuticals, Inc. | 22.71M | 3.73% | 8,591 | - |
| 529 | BCTX | BriaCell Therapeutics Corp. | 22.44M | -2.78% | 129,624 | - |
| 530 | FBRX | Forte Biosciences, Inc. | 21.90M | -4.76% | 29,907 | - |
| 531 | NRSN | NeuroSense Therapeutics Ltd. | 20.98M | 0.83% | 56,029 | - |
| 532 | VINC | Vincerx Pharma, Inc. | 20.86M | -1.81% | 264,886 | - |
| 533 | AIM | AIM ImmunoTech Inc. | 20.86M | 4.97% | 217,509 | 193.00K |
| 534 | COCP | Cocrystal Pharma, Inc. | 20.86M | 2.56% | 6,792 | - |
| 535 | MEIP | MEI Pharma, Inc. | 20.72M | 6.14% | 9,345 | 66.75M |
| 536 | LUMO | Lumos Pharma, Inc. | 20.62M | -2.64% | 6,941 | 1.53M |
| 537 | INDP | Indaptus Therapeutics, Inc. | 20.49M | 4.72% | 25,250 | - |
| 538 | SLGL | Sol-Gel Technologies Ltd. | 20.05M | 0.24% | 45,393 | 1.55M |
| 539 | ORGS | Orgenesis Inc. | 19.89M | 5.69% | 47,214 | 530.00K |
| 540 | SYBX | Synlogic, Inc. | 19.55M | -0.60% | 8,794 | 3.21M |
| 541 | EVAX | Evaxion Biotech A/S | 19.55M | -2.65% | 3,935 | 73.00K |
| 542 | TCRT | Alaunos Therapeutics, Inc. | 19.11M | -2.46% | 9,907 | 5.00K |
| 543 | GLYC | GlycoMimetics, Inc. | 18.99M | 4.73% | 2,019,490 | 10.00K |
| 544 | NRXS | NeurAxis, Inc. | 18.93M | -7.12% | 1,649 | 2.46M |
| 545 | APTO | Aptose Biosciences Inc. | 18.92M | -1.68% | 72,996 | - |
| 546 | TNXP | Tonix Pharmaceuticals Holding Corp. | 18.87M | 8.59% | 6,065,217 | 10.25M |
| 547 | KALA | Kala Pharmaceuticals, Inc. | 18.31M | -2.69% | 1,753 | - |
| 548 | PHGE | BiomX Inc. | 18.10M | -0.70% | 140,595 | - |
| 549 | VBIV | VBI Vaccines Inc. | 18.07M | -2.68% | 128,362 | 9.41M |
| 550 | PMCB | PharmaCyte Biotech, Inc. | 17.92M | 3.85% | 1,698 | - |
| 551 | NERV | Minerva Neurosciences, Inc. | 17.76M | 1.20% | 1,341 | - |
| 552 | SNTI | Senti Biosciences, Inc. | 17.20M | -1.08% | 62,184 | 1.28M |
| 553 | GLTO | Galecto, Inc. | 17.09M | -1.10% | 31,973 | - |
| 554 | ATHE | Alterity Therapeutics Limited | 16.96M | -2.02% | 8,769 | - |
| 555 | IBIO | iBio, Inc. | 16.93M | 7.73% | 248,765 | 50.00K |
| 556 | CDIO | Cardio Diagnostics Holdings, Inc. | 16.68M | -12.87% | 612,497 | 32.99K |
| 557 | TRAW | Traws Pharma, Inc. | 16.19M | 0.84% | 41,906 | 226.00K |
| 558 | XTLB | XTL Biopharmaceuticals Ltd. | 15.26M | 3.79% | 4,235 | - |
| 559 | EDSA | Edesa Biotech, Inc. | 14.95M | 3.79% | 13,379 | - |
| 560 | PPBT | Purple Biotech Ltd. | 14.57M | 9.56% | 109,886 | - |
| 561 | KPRX | Kiora Pharmaceuticals, Inc. | 14.48M | -5.14% | 131,711 | 16.00M |
| 562 | IMRN | Immuron Limited | 14.03M | 1.75% | 568 | 2.43M |
| 563 | PIRS | Pieris Pharmaceuticals, Inc. | 13.75M | 0.14% | 1,709 | 40.93M |
| 564 | ONVO | Organovo Holdings, Inc. | 13.38M | -0.96% | 31,817 | 242.00K |
| 565 | IMNN | Imunon, Inc. | 13.38M | 1.64% | 8,995 | - |
| 566 | COEP | Coeptis Therapeutics, Inc. | 13.37M | 1.32% | 14,295 | - |
| 567 | ADXN | Addex Therapeutics Ltd | 12.78M | -1.38% | 5,714 | 1.96M |
| 568 | DOMH | Dominari Holdings Inc. | 12.70M | 3.88% | 3,160 | 3.41M |
| 569 | CMMB | Chemomab Therapeutics Ltd. | 12.36M | -1.21% | 20,464 | - |
| 570 | ELAB | Elevai Labs, Inc. | 11.79M | 5.75% | 125,367 | 2.18M |
| 571 | AKTX | Akari Therapeutics, Plc | 11.74M | -3.92% | 15,801 | - |
| 572 | MBRX | Moleculin Biotech, Inc. | 11.65M | - | 11,733 | - |
| 573 | CLDI | Calidi Biotherapeutics, Inc. | 11.59M | -5.99% | 186,036 | - |
| 574 | ALLR | Allarity Therapeutics, Inc. | 11.43M | -3.69% | 3,409,961 | - |
| 575 | CANF | Can-Fite BioPharma Ltd. | 11.38M | 1.90% | 30,840 | 743.00K |
| 576 | ABVC | ABVC BioPharma, Inc. | 11.30M | 0.94% | 106,123 | 152.43K |
| 577 | IKT | Inhibikase Therapeutics, Inc. | 11.29M | -0.97% | 36,279 | 195.98K |
| 578 | GRTX | Galera Therapeutics, Inc. | 11.23M | 7.22% | 834,429 | - |
| 579 | ERNA | Eterna Therapeutics Inc. | 10.82M | -1.48% | 11,807 | 115.00K |
| 580 | BCDA | BioCardia, Inc. | 10.71M | -0.98% | 58,923 | 468.00K |
| 581 | MNPR | Monopar Therapeutics Inc. | 10.67M | -0.34% | 35,349 | - |
| 582 | AEZS | Aeterna Zentaris Inc. | 10.34M | -0.35% | 5,593 | 4.50M |
| 583 | FRES | Fresh2 Group Ltd | 10.27M | 5.11% | 8,785 | 2.35M |
| 584 | AVTX | Avalo Therapeutics, Inc. | 9.99M | 0.21% | 48,398 | 1.45M |
| 585 | CHRO | Chromocell Therapeutics Corporation | 9.82M | -16.92% | 43,615 | - |
| 586 | BNOX | Bionomics Limited | 9.66M | -2.38% | 25,599 | 15.00K |
| 587 | PSTV | Plus Therapeutics, Inc. | 9.62M | -0.04% | 31,509 | 6.08M |
| 588 | MTEM | Molecular Templates, Inc. | 9.55M | - | 18,374 | 31.76M |
| 589 | OGEN | Oragenics, Inc. | 9.31M | 28.05% | 390,899 | 20.63K |
| 590 | NTBL | Notable Labs, Ltd. | 9.19M | -1.92% | 100,414 | 311.00K |
| 591 | EFTR | eFFECTOR Therapeutics, Inc. | 9.17M | -2.02% | 53,580 | - |
| 592 | BRTX | BioRestorative Therapies, Inc. | 9.14M | -2.17% | 30,584 | 145.80K |
| 593 | LGVN | Longeveron Inc. | 8.18M | 0.78% | 145,180 | 978.00K |
| 594 | KTRA | Kintara Therapeutics, Inc. | 7.93M | -1.31% | 12,521,899 | - |
| 595 | VCNX | Vaccinex, Inc. | 7.89M | 6.36% | 3,364 | 124.00K |
| 596 | CYCN | Cyclerion Therapeutics, Inc. | 7.72M | -4.36% | 1,157 | - |
| 597 | TRVN | Trevena, Inc. | 7.72M | 3.56% | 9,549 | 3.14M |
| 598 | ASLN | ASLAN Pharmaceuticals Limited | 7.67M | 0.23% | 162,985 | 12.00M |
| 599 | NCNA | NuCana plc | 7.51M | -3.11% | 14,674 | - |
| 600 | RNAZ | TransCode Therapeutics, Inc. | 7.49M | 28.84% | 3,687,350 | - |
| 601 | HEPA | Hepion Pharmaceuticals, Inc. | 7.33M | 3.23% | 24,290 | - |
| 602 | FWBI | First Wave BioPharma, Inc. | 7.33M | 4.59% | 56,525 | - |
| 603 | VIRI | Virios Therapeutics, Inc. | 7.24M | 2.33% | 98,510 | - |
| 604 | PULM | Pulmatrix, Inc. | 7.01M | 1.56% | 7,437 | 11.68M |
| 605 | TENX | Tenax Therapeutics, Inc. | 6.91M | -1.94% | 11,464 | - |
| 606 | KTTA | Pasithea Therapeutics Corp. | 6.89M | -1.79% | 392 | - |
| 607 | PYPD | PolyPid Ltd. | 6.85M | -4.83% | 8,976 | - |
| 608 | KZIA | Kazia Therapeutics Limited | 6.82M | 4.95% | 34,586 | 15.65K |
| 609 | ENVB | Enveric Biosciences, Inc. | 6.81M | -5.56% | 180,767 | - |
| 610 | TFFP | TFF Pharmaceuticals, Inc. | 6.75M | -4.42% | 10,495 | 885.72K |
| 611 | CVKD | Cadrenal Therapeutics, Inc. | 6.66M | -3.28% | 124,813 | - |
| 612 | PTIX | Protagenic Therapeutics, Inc. | 6.65M | 10.29% | 4,795 | - |
| 613 | ADIL | Adial Pharmaceuticals, Inc. | 6.56M | 8.94% | 108,267 | - |
| 614 | NLSP | NLS Pharmaceutics AG | 6.50M | 10.11% | 674,491 | - |
| 615 | TOVX | Theriva Biologics, Inc. | 6.48M | 2.67% | 31,169 | - |
| 616 | SNGX | Soligenix, Inc. | 6.08M | 1.41% | 139,855 | 699.21K |
| 617 | PALI | Palisade Bio, Inc. | 5.89M | -2.71% | 23,939 | - |
| 618 | CELZ | Creative Medical Technology Holdings, Inc. | 5.85M | -0.44% | 1,075 | 9.00K |
| 619 | HOTH | Hoth Therapeutics, Inc. | 5.78M | -0.84% | 13,057 | - |
| 620 | LIPO | Lipella Pharmaceuticals Inc. | 5.74M | 2.31% | 55,376 | 477.45K |
| 621 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 5.66M | 0.56% | 27,876 | 92.73K |
| 622 | XBIO | Xenetic Biosciences, Inc. | 5.62M | 2.24% | 1,614 | 2.44M |
| 623 | TTNP | Titan Pharmaceuticals, Inc. | 5.56M | 1.58% | 11,344 | 87.00K |
| 624 | PCSA | Processa Pharmaceuticals, Inc. | 5.54M | -4.00% | 30,444 | - |
| 625 | AZTR | Azitra, Inc. | 5.50M | -4.24% | 11,256,369 | 572.70K |
| 626 | SILO | Silo Pharma, Inc. | 5.48M | 5.68% | 45,044 | 72.10K |
| 627 | MYMD | MyMD Pharmaceuticals, Inc. | 5.45M | 2.23% | 15,028 | - |
| 628 | LIXT | Lixte Biotechnology Holdings, Inc. | 5.35M | 2.90% | 3,174 | - |
| 629 | KA | Kineta, Inc. | 5.34M | -1.69% | 36,417 | 5.16M |
| 630 | GNPX | Genprex, Inc. | 5.25M | 2.04% | 16,526 | - |
| 631 | SNPX | Synaptogenix, Inc. | 5.25M | -0.33% | 23,332 | - |
| 632 | NBY | NovaBay Pharmaceuticals, Inc. | 4.98M | 8.42% | 129,763,076 | 14.23M |
| 633 | ENSC | Ensysce Biosciences, Inc. | 4.82M | 0.76% | 124,983 | - |
| 634 | PRTG | Portage Biotech Inc. | 4.79M | -8.94% | 138,551 | - |
| 635 | DRUG | Bright Minds Biosciences Inc. | 4.75M | -1.83% | 9,077 | - |
| 636 | NEXI | NexImmune, Inc. | 4.69M | 0.56% | 2,493 | - |
| 637 | XRTX | XORTX Therapeutics Inc. | 4.64M | -2.88% | 6,724 | - |
| 638 | ALZN | Alzamend Neuro, Inc. | 4.54M | 2.45% | 24,256 | - |
| 639 | GTBP | GT Biopharma, Inc. | 4.49M | -0.31% | 1,753 | - |
| 640 | ARTL | Artelo Biosciences, Inc. | 4.49M | 7.46% | 23,362 | - |
| 641 | XCUR | Exicure, Inc. | 4.38M | -1.17% | 32,887 | 21.77M |
| 642 | THAR | Tharimmune, Inc. | 4.36M | 0.43% | 74,976 | - |
| 643 | SEEL | Seelos Therapeutics, Inc. | 4.11M | -19.66% | 212,408 | 1.97M |
| 644 | SCPX | Scorpius Holdings, Inc. | 4.03M | 9.99% | 63,995,517 | 6.99M |
| 645 | CMND | Clearmind Medicine Inc. | 3.97M | -4.19% | 188,707 | - |
| 646 | MBIO | Mustang Bio, Inc. | 3.96M | 5.60% | 141,088 | - |
| 647 | ADTX | Aditxt, Inc. | 3.94M | -0.99% | 16,249 | 645.18K |
| 648 | GOVX | GeoVax Labs, Inc. | 3.92M | -2.30% | 20,298 | - |
| 649 | TCON | TRACON Pharmaceuticals, Inc. | 3.88M | -5.88% | 97,761 | 12.15M |
| 650 | PHIO | Phio Pharmaceuticals Corp. | 3.64M | 4.30% | 271,712 | - |
| 651 | TCBP | TC Biopharm (Holdings) Plc | 3.61M | - | 166,568 | - |
| 652 | ATXI | Avenue Therapeutics, Inc. | 3.54M | - | 32,272 | - |
| 653 | ONCO | Onconetix, Inc. | 3.50M | 11.99% | 15,393,087 | 58.47K |
| 654 | ZVSA | ZyVersa Therapeutics, Inc. | 3.45M | -6.79% | 89,706 | - |
| 655 | CYTO | Altamira Therapeutics Ltd. | 3.43M | 1.32% | 13,501 | - |
| 656 | BPTH | Bio-Path Holdings, Inc. | 3.38M | -7.48% | 55,477 | - |
| 657 | CYCC | Cyclacel Pharmaceuticals, Inc. | 3.34M | -2.56% | 23,048 | 449.00K |
| 658 | APVO | Aptevo Therapeutics Inc. | 3.28M | 0.49% | 133,044 | - |
| 659 | FNCH | Finch Therapeutics Group, Inc. | 3.21M | 2.56% | 8,367 | - |
| 660 | REVB | Revelation Biosciences, Inc. | 3.21M | 8.60% | 22,596 | - |
| 661 | CING | Cingulate Inc. | 3.10M | -1.27% | 14,378 | - |
| 662 | SPRC | SciSparc Ltd. | 2.97M | 0.83% | 48,798 | 2.88M |
| 663 | QNRX | Quoin Pharmaceuticals, Ltd. | 2.94M | -2.04% | 31,862 | - |
| 664 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.75M | 6.73% | 1,179,213 | 569.86K |
| 665 | SCNI | Scinai Immunotherapeutics Ltd. | 2.61M | -2.00% | 14,450 | - |
| 666 | CNSP | CNS Pharmaceuticals, Inc. | 2.36M | -3.56% | 163,274 | - |
| 667 | GLMD | Galmed Pharmaceuticals Ltd. | 2.34M | -0.55% | 69,020 | - |
| 668 | WINT | Windtree Therapeutics, Inc. | 2.28M | 3.93% | 7,114 | - |
| 669 | SLRX | Salarius Pharmaceuticals, Inc. | 2.27M | 4.72% | 7,860 | - |
| 670 | QLGN | Qualigen Therapeutics, Inc. | 1.99M | -2.37% | 142,183 | - |
| 671 | VRAX | Virax Biolabs Group Limited | 1.98M | 4.69% | 22,109 | 79.30K |
| 672 | DRMA | Dermata Therapeutics, Inc. | 1.94M | -11.06% | 50,517 | - |
| 673 | INM | InMed Pharmaceuticals Inc. | 1.74M | 5.35% | 2,050,880 | 5.63M |
| 674 | GRI | GRI Bio, Inc. | 1.57M | -0.58% | 227,723 | - |
| 675 | NBSE | NeuBase Therapeutics, Inc. | 1.42M | -1.56% | 97,744 | - |
| 676 | ATNF | 180 Life Sciences Corp. | 1.36M | - | 48,541 | - |
| 677 | VRPX | Virpax Pharmaceuticals, Inc. | 935.81K | -0.14% | 222,073 | - |
| 678 | BDRX | Biodexa Pharmaceuticals Plc | 275.09K | -2.42% | 422,688 | 482.28K |